Translational Research Cancer Centers Consortium
Expediting Progress in Cancer Immunotherapy
Anna Gutkina
Ovarian Cancer
Philadelphia, PA
TRCCC Advocate: 2016
Anna Gutkina survived stage 4 BRCA1 ovarian cancer due to combination immunotherapy with dendritic cells, immune checkpoint blockers and cancer stem cells that was made overseas. Anna's book "Defusing the Cancer Bomb" tells her vaccine story and is available on Amazon. Anna is the patient advocate. She wants to bring more of the similar treatments to the US by bringing together doctors, researchers, patients and business processes. Her start-up, Freencer Labs works on digital research and big data in cancer, consults on taking scientific inventions in immunotherapy to the market by company formation, strategy, intellectual property creation, marketing, and clinical trials. Anna lives in the Philadelphia area.